Olink

Olink®
Part of Thermo Fisher Scientific

Scientific publications

Discover the latest research using Olink’s panels for protein biomarker discovery through our comprehensive list of publications. Easily find relevant studies by filtering them or using the free-text search.  Access abstracts, PubMed entries, and full-text papers directly through the links provided.

Filter

Filters

Publication
Disease Area
Application Area
Sample Type
Products

Journal of Proteome Research, 2025

Demarcating the Development of Cirrhosis and Its Complications via Plasma Proteomic Features in an Asymptomatic Population

Liang Z., Li Z., Jin H. et al.

Journal of Translational Medicine, 2025

Beta-blockers prolong response to androgen deprivation therapy in prostate cancer through modulation of the neuro-immuno-oncology axis

Thulin M., Ramberg H., Nielsen H. et al.

Immunity, 2025

A conserved immune dysregulation signature is associated with infection severity, risk factors prior to infection, and treatment response

Ganesan A., Moore A., Zheng H. et al.

Circulation: Genomic and Precision Medicine, 2025

Machine Learning-Based Plasma Protein Risk Score Improves Atrial Fibrillation Prediction Over Clinical and Genomic Models

Kim M., Khurshid S., Kany S. et al.

Brain and Behavior, 2025

Association of Sleep, Inflammation and Female Infertility: A Cross‐Sectional Survey and Genetic Approach

Xin X., Li J., Zhang J. et al.

eBioMedicine, 2025

GDF15 and its receptors as pathways mediating smoking related weight change

Tinworth A., Iona A., Yao P. et al.

Schizophrenia, 2025

Cardiovascular protein profiling in patients with first-episode psychosis

Malmqvist A., Eren F., Schwieler L. et al.

The FASEB Journal, 2025

Genomic Locus Tagged by Lung Function GWAS SNV rs12477314 (2q37.3) Acts as a Regulatory Region for a Systemic Inflammatory Phenotype

Grech G., Fawcett K., Hall R. et al.

Journal of Allergy and Clinical Immunology: Global, 2025

Type-2 immune responses are associated with less severe COVID-19 in a hospitalized cohort

Jayavelu N., Qi J., Milliren C. et al.

Communications Medicine, 2025

Deep plasma proteomics identifies and validates an eight-protein biomarker panel that separate benign from malignant tumors in ovarian cancer

Moskov M., Hedlund Lindberg J., Lycke M. et al.

Brain and Behavior, 2025

Proteome‐Wide and Immune Cell Phenotype Mendelian Randomization Highlights Immune Involvement in Genetic Generalized Epilepsy

Gui J., Chu H., Zhang J. et al.

Brain and Behavior, 2025

Exploring the Causal Association Between 91 Circulating Inflammatory Proteins and Neurodegenerative Diseases: A Bidirectional Two‐Sample Mendelian Randomization and Bioinformatics Analysis

Gong Z., Cao R., Zhu H.

Discover Oncology, 2025

Genetically predicted immune cells mediates the association between hepatocellular carcinoma and inflammatory proteins: a Mendelian randomization study

Wang Y., Tao Z., Cheng Y. et al.

Clinical Breast Cancer, 2025

The Role of 473 Intestinal Microbiota and 91 Inflammatory Factors in Breast Cancer Risk: Insights From Mendel Randomization and its Implications for Diagnosis and Treatment

Zhu R., Qiu J., Xian D. et al.

PLOS One, 2025

Associations between physical activity and CVD-related metabolomic and proteomic biomarkers

Ekblom ?., Björkbacka H., Börjesson M. et al.

Journal of Inflammation Research, 2025

Novel Proteomic Insights into Hip Fractures in the Elderly: Unraveling Immunologic Biomarkers, Temporal Expression Patterns, and Clinical Correlations

Lu Y., Liu J., Chen W. et al.

Nutrition & Metabolism, 2025

Integrative multi-omics investigation of sleep apnea: gut microbiome metabolomics, proteomics and phenome-wide association study

Wei S., Shen R., Lu X. et al.

Frontiers in Immunology, 2025

Case Report: Serum sickness induced by dupilumab—clinical insights and Olinkproteomic analysis

Zhu H., Huang Q., Zheng L. et al.

Medicine, 2025

Cytokines and oral cancer risk: Genetic evidence from a bidirectional Mendelian randomization study

Shi W., Zhang A., Xu Y. et al.

Journal of Affective Disorders, 2025

Exploring causal plasma protein level ratios and potential drug targets for depression: A proteomics Mendelian randomization study

Zhang G., Hao J., Ren Q. et al.

4586 publications